BerandaINO • NASDAQ
add
Inovio Pharmaceuticals Inc
$5,61
Setelah Jam Perdagangan Normal:(0,00%)0,00
$5,61
Tutup: 18 Okt, 16.02.31 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$5,67
Rentang hari
$5,55 - $5,75
Rentang tahun
$3,89 - $14,75
Kapitalisasi pasar
145,66Â jt USD
Volume Rata-Rata
328,24Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 100,76Â rb | -55,41% |
Biaya operasional | 10,21Â jt | -24,52% |
Laba bersih | -32,24Â jt | 9,28% |
Margin laba bersih | -31,99Â rb | -103,45% |
Penghasilan per saham | -1,19 | 23,72% |
EBITDA | -32,71Â jt | 9,84% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 110,42Â jt | -43,35% |
Total aset | 133,80Â jt | -42,59% |
Total liabilitas | 37,06Â jt | -41,79% |
Total ekuitas | 96,74 jt | — |
Saham yang beredar | 25,96 jt | — |
Harga terhadap nilai buku | 1,52 | — |
Tingkat pengembalian aset | -63,13% | — |
Tingkat pengembalian modal | -76,28% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -32,24Â jt | 9,28% |
Kas dari operasi | -28,21Â jt | 12,70% |
Kas dari investasi | 9,97Â jt | -81,51% |
Kas dari pembiayaan | 33,03Â jt | 1.045,85% |
Perubahan kas bersih | 14,79Â jt | -39,57% |
Arus kas bebas | -17,10Â jt | 17,80% |
Tentang
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Didirikan
1999
Situs
Karyawan
127
